Teva Adderall Seen in Short Supply Through March, FDA Says (1)

Teva Pharmaceutical Industries Ltd.’s shortage of Adderall is expected to last through March, longer than the two to three months the company said last week, according to US regulators.

The popular treatment for attention-deficit/hyperactivity disorder has been in short supply since at least August, leaving people racing to fill prescriptions and find pharmacies with the elusive medication in stock. Demand for the drug is at an all-time high, and Teva sells more Adderall in the US than any other drug company.

Teva “is experiencing ongoing intermittent manufacturing delays,” the FDA said on its website on Wednesday. While ...